Affiliation:
1. Sechenov First Moscow State Medical University (Sechenov University)
2. Yevdokimov Moscow State University of Medicine and Dentistry
3. Herzen Moscow Oncology Research Center - Branch of the National Medical Research Radiology Center
4. Privolzhsky Research Medical University, Nizhny Novgorod
5. Rostov State Medical University
6. Saint-Petersburg State Pediatric Medical University; Pavlov First Saint-Petersburg State Medical University
Abstract
Aim. Current clinical recommendations aim to provide gastroenterologists, general practitioners (family doctors), endoscopists and infectionists with modern methods for diagnosis and treatment of infectious esophagitis.Key points. Infectious esophagitis is an esophageal disease of fungal, viral, bacterial or parasitic origin. Esophagus may be affected per se or conjointly in a common gastrointestinal infection. All patients suspected for infectious esophagitis, unless contraindicated, are advised an esophagogastroduodenoscopy with biopsy to confirm diagnosis. Selected incidents of infectious esophagitis require a histological, immunohistochemical examination or polymerase chain reaction-based diagnosis to verify the infectious agent. Uncomplicated infectious esophagitis requires a conservative therapy, mostly on an outpatient basis. However, cases of severe odynophagia, dysphagia, severe pain syndrome, high complication risks (e.g., esophageal ulcer bleeding in thrombocytopenia), severe immunodeficiency, generalised forms of disease and severe concomitant disorders are considered for hospital care. The clinical recommendations outline criteria for the medical care quality assessment and provide relevant information to the patient.Conclusion. Diagnosis of infectious esophagitis capitalises on the clinical picture (odynophagia, dysphagia), presence of immunosuppression, endoscopic and histological evidence. All patients with infectious esophagitis of verified origin are recommended a suitable etiotropic therapy.
Publisher
Russian Gastroenterolgocial Society
Reference106 articles.
1. Wilcox C.M. Esophagitis in the immunocompromised host. In: Castell D.O., Richter J.E., eds. The esophagus, 5th ed. Philadelphia: Lippincott-Raven, 2012:724–39. DOI: 10.1002/9781444346220.ch39. 5
2. Ivashkin V.T., Jushhuk N.D., Maev I.V., Truhmanov A.S., Alekseyeva O.P., Lapina T.L., Pirogov S.S., Tkachev A.V., Sheptulin A.A. Diagnostics and treatment of infectious esophagitis: clinical guidelines of the Russian gastroenterological association. Rus J Gastroent Hepatol Coloproctol. 2015;25(6):77–81 (In Russ.).
3. O’Rourke A. Infective oesophagitis: epidemiology, cause, diagnosis and treatment options. Curr Opin Otolaryngol. Head Neck Surg. 2015;23(6):459–63. DOI: 10.1097/МОО.0000000000000199
4. Mulhall B.P., Wong R.K.H. Infectious Esophagitis. Curr Treat Options Gastroenterol. 2003;6(1):55–70. DOI: 10.1007/s11938-003-0034-5
5. Forrest G. Gastrointestinal infections in immunocompromised hosts. Curr Opin Gastroenterol. 2004;20(1):16–21. DOI: 10.1097/00001574-200401000-00005